A Multicenter Random Single Blind Parallelism Drugs Contrast Eeperiment of Treatment of Pristine HAPE with Diffrent Projects

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2012
INTERVENTION: A group:aminophylline;B group:dexamethasone;C group:nifedipine; CONDITION: acute altitude disease PRIMARY OUTCOME: recovery rate;progressed HAPE incidence rate; SECONDARY OUTCOME: average recovery time;average time to be in hospital;Adverse Event incidence rate; INCLUSION CRITERIA: 1. 18 to 60 years of age; 2. Patient of achieved the diagnostic criteria of early HAPE Agreement; 3. Patients signed the informed consent.
Epistemonikos ID: c49ad783ad6ecb23486e5d7f075713e201220a65
First added on: Aug 22, 2024